These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 12636985)

  • 1. The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000.
    Lu PL; Lee YW; Peng CF; Tsai JJ; Chen YH; Hwang KP; Chen TP
    Int J Antimicrob Agents; 2003 Mar; 21(3):239-43. PubMed ID: 12636985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.
    Khan MY; Kinsara AJ; Osoba AO; Wali S; Samman Y; Memish Z
    Int J Antimicrob Agents; 2001 May; 17(5):415-8. PubMed ID: 11337231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Nairobi.
    Ndung'u PW; Kariuki S; Ng'ang'a Z; Revathi G
    J Infect Dev Ctries; 2012 Jan; 6(1):33-9. PubMed ID: 22240426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risks, and transmission dynamics.
    Wilkinson D; Pillay M; Davies GR; Sturm AW
    Trans R Soc Trop Med Hyg; 1996; 90(6):692-5. PubMed ID: 9015521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antimicrobial resistance in tuberculosis].
    Gutiérrez-Aroca JB; Ruiz P; Casal M
    Rev Esp Quimioter; 2013 Dec; 26(4):332-6. PubMed ID: 24399346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-resistant Mycobacterium tuberculosis among new tuberculosis patients, Yangon, Myanmar.
    Phyu S; Ti T; Jureen R; Hmun T; Myint H; Htun A; Grewal HM; Bjorvatn B
    Emerg Infect Dis; 2003 Feb; 9(2):274-6. PubMed ID: 12604008
    [No Abstract]   [Full Text] [Related]  

  • 7. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line anti-tuberculosis drug resistance trends of Mycobacterium tuberculosis complex isolates. A tertiary hospital study in Turkey.
    Yazısız H; Hırçın Cenger D; Yazısız V; Kılıç L; Altın S
    Tuberk Toraks; 2019 Jun; 67(2):92-101. PubMed ID: 31414639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the prevalence of primary drug resistance in pulmonary tuberculosis in France from 1962 to 1970: a national survey.
    Canetti G; Gay P; Le Lirzin M
    Tubercle; 1972 Jun; 53(2):57-83. PubMed ID: 4114335
    [No Abstract]   [Full Text] [Related]  

  • 13. Activity of twelve second-line antimicrobial agents against Mycobacterium tuberculosis in Taiwan.
    Lu PL; Peng CF; Hwang JJ; Chen YH
    J Chemother; 2008 Apr; 20(2):202-7. PubMed ID: 18467246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology and drug sensitivity pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in and around Ambo Town, Central Ethiopia.
    Tilahun M; Ameni G; Desta K; Zewude A; Yamuah L; Abebe M; Aseffa A
    PLoS One; 2018; 13(2):e0193083. PubMed ID: 29447273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone-resistant tuberculosis at a medical centre in Taiwan, 2005-10.
    Lai CC; Tan CK; Huang YT; Liao CH; Hsueh PR
    J Antimicrob Chemother; 2011 Oct; 66(10):2437-8. PubMed ID: 21798881
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.
    Al-Hajoj S; Varghese B; Shoukri MM; Al-Omari R; Al-Herbwai M; Alrabiah F; Alrajhi AA; Abuljadayel N; Al-Thawadi S; Zumla A; Zignol M; Raviglione MC; Memish Z
    Antimicrob Agents Chemother; 2013 May; 57(5):2161-6. PubMed ID: 23459478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretome profile analysis of multidrug-resistant, monodrug-resistant and drug-susceptible Mycobacterium tuberculosis.
    Putim C; Phaonakrop N; Jaresitthikunchai J; Gamngoen R; Tragoolpua K; Intorasoot S; Anukool U; Tharincharoen CS; Phunpae P; Tayapiwatana C; Kasinrerk W; Roytrakul S; Butr-Indr B
    Arch Microbiol; 2018 Mar; 200(2):299-309. PubMed ID: 29119205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
    Al-Marri MR
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to first- and second-line antituberculosis drugs in Southern Taiwan: Implications for empirical treatment.
    Kuo CY; Wang WH; Huang CH; Chen YH; Lu PL
    J Microbiol Immunol Infect; 2018 Feb; 51(1):88-93. PubMed ID: 28698044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.